(Q73267440)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10595789%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Occurrence of anti-prothrombin and anti-beta2-glycoprotein I antibodies in patients with history of thrombosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10595789%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

Forastiero R

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10595789%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Martinuzzo M

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10595789%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Adamczuk Y

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10595789%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Carreras LO

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10595789%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 December 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10595789%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

published in

Translational Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10595789%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

134

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10595789%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10595789%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

610-615

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10595789%20AND%20SRC:MED&resulttype=core&format=json

Special report. The Second International Anti-cardiolipin Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) group

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990101-4

Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990101-4

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990101-4

Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990101-4

Immunology of the antiphospholipid antibody syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990101-4

The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta2 glycoprotein 1 (and other proteins)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990101-4

Association of anti-beta 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990101-4

Measurement of anti-phospholipid antibodies by ELISA using beta 2-glycoprotein I as an antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990101-4

Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990101-4

Anti beta 2 glycoprotein I antibodies: detection and association with thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990101-4

Anti-beta 2-glycoprotein I antibodies: a marker of antiphospholipid syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990101-4

Antibodies to phospholipid-binding plasma proteins and occurrence of thrombosis in patients with systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990101-4

Antibodies to beta2-glycoprotein I--a specific marker for the antiphospholipid syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990101-4

Antibodies against phospholipids and beta 2-glycoprotein I increase the risk of recurrent venous thromboembolism in patients without systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990101-4

The antiphospholipid/cofactor syndromes: a primary variant with antibodies to beta 2-glycoprotein-I but no antibodies detectable in standard antiphospholipid assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990101-4

10.1016/S0022-2143(99)90101-4

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10595789%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference